Saini, Kamal S.
Lanza, Carlo
Romano, Marco
de Azambuja, Evandro
Cortes, Javier
de las Heras, Begoña
de Castro, Javier
Lamba Saini, Monika
Loibl, Sibylle
Curigliano, Giuseppe
Twelves, Chris
Leone, Manuela http://orcid.org/0000-0002-6640-0037
Patnaik, Mrinal M.
Article History
Received: 7 May 2020
Revised: 21 May 2020
Accepted: 4 June 2020
First Online: 22 June 2020
Ethics approval and consent to participate
: Not applicable.
: Not applicable.
: All data mentioned in this manuscript are from publicly available sources.
: K.S.S. reports consulting fees from the European Commission outside the submitted work. C.L. reports consulting fees from Anaveon AG, Akebia Therapeutics Inc, and Ergomed Plc outside the submitted work. E.d.A. reports honoraria and advisory board from Roche/GNE, Novartis, and Seattle Genetics; travel grants from Roche/GNE GSK and Novartis; and research grant to institution from Roche/GNE, AstraZeneca, GSK, Novartis, and Servier outside the submitted work. J.C. reports consulting/advisory fees from Roche, Celgene, Cellestia, AstraZeneca, Biothera Pharmaceutical, Merus, Seattle Genetics, Daiichi Sankyo, Erytech, Athenex, Polyphor, Lilly, Servier, Merck Sharp&Dohme, GSK, Leuko, Bioasis, Clovis Oncology, and Boehringer Ingelheim; honoraria from Roche, Novartis, Celgene, Eisai, Pfizer, Samsung Bioepis, Lilly, Merck Sharp&Dohme, and Daiichi Sankyo; research funding to his institution from Roche, Ariad, AstraZeneca, Baxalta GMBH/Servier Affaires, Bayer Healthcare, Eisai, F.Hoffman-La Roche, Guardanth Health, Merck Sharp&Dohme, Pfizer, Piqur Therapeutics, Puma C, and Queen Mary University of London; stock, patents, and intellectual property from MedSIR; travel, accommodation and expenses from Roche, Novartis, Eisai, Pfizer, and Daiichi Sankyo outside the submitted work. G.C. reports personal fees for consulting, advisory role, and speakers’ bureau from Roche/Genentech, Novartis, Pfizer, Lilly, Foundation Medicine, Samsung, and Daichii-Sankyo; honoraria from Ellipses Pharma; fees for travel and accommodation from Roche/Genentech and Pfizer outside the submitted work. Other authors do not report any competing interests.
: No funding was received for the preparation of this manuscript.